Genetic and blood test to predict early recurrence in colorectal cancer spread to liver
Part of Cancer, Digestive system clinical trials.
This study looks at your tumor's genetic makeup and a blood test after surgery to better predict if colorectal cancer that spread to the liver might come back early. The goal is to personalize follow-up care and potentially guide additional treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your colorectal cancer has spread to the liver, and both the original tumor and the liver tumors were completely removed with surgery.
- You have enough liver tumor tissue saved for genetic testing, and you can give a blood sample within a month after surgery.
- You are generally healthy enough to receive other treatments like chemotherapy or radiation if needed.
- You do not have other cancers, serious heart disease, uncontrolled infections, or psychiatric conditions that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses your liver MRI scans and medical information to build a tool that predicts survival after surgery for colorectal cancer that has spread to the liver. It may help doctors better understand your outlook and plan care.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This study compares two different types of liver surgery for people with colorectal cancer that has spread to the liver and who have specific genetic changes or a right-sided primary tumor. You will be randomly assigned to one surgery type, and researchers will track how well you do over time to see if one approach is better.
This study looks at MRI scans and tissue samples from people with colorectal cancer that has spread to the liver. The goal is to find patterns that might predict whether the cancer will come back after surgery, which could help guide future treatment.
This trial studies a blood test (called ctDNA) in people with colon cancer that has spread to the liver and is being removed with curative surgery. The goal is to see how the blood test can help with planning and improving treatment after surgery.
Hear when a new Colorectal Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.